You can now review and comment on this draft addendum.

NICE has updated its guidance on Headaches for use in the NHS in England, Wales and Northern Ireland. The NICE guideline on headaches was reviewed by the NICE surveillance team, and new evidence on pharmacological treatment for migraine prophylaxis was identified.  The aim of this update is to review current evidence on pharmacological prophylactic treatment for migraine. 

The consultation closes on 1 September at 5pm

How to comment

1.Register your organisation

Your organisation needs to be registered as a stakeholder before we can accept comments.

Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.

2. Read the consultation documents

Documents to comment on:

• Draft addendum
• Short guideline – just the recommendations
• Economic model

If you want to review the economic model, fill in this confidentiality form and email it to: HAUpdate@nice.org.uk

Other information about the consultation:

• Equality impact assessment

3. Add your comments

You must use this form.

If you share similar views with another organisation, send a joint response.

Make sure you consider:

• The areas that will have the biggest impact on practice and be challenging to implement
• How to help users overcome challenges

Developing NICE guidelines: how to get involved suggests some other areas to comment on.

4. Email the form to us

Email: HAUpdate@nice.org.uk

Deadline: 1 September 2015, 5pm